Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools


You are here: Home
197 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Predictive biomarkers for lung cancer reported in laboratory finding
by maryruth.helms published Mar 26, 2012 last modified Mar 30, 2012 02:54 PM — filed under: , ,
A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.
Located in News / 2012 News
Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit
by maryruth.helms published Apr 02, 2012 last modified Apr 02, 2012 04:42 PM — filed under: , ,
Chapel Hill - In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit.
Located in News / 2012 News
Hematologic malignancies rapidly increasing and unaddressed in sub-Saharan Africa
by maryruth.helms published Apr 03, 2012 last modified Apr 03, 2012 09:42 AM — filed under: , , ,
UNC-led team offers clinical, research agenda
Located in News / 2012 News
Evans quoted in The News & Observer, Scientific American Blog
by maryruth.helms published Apr 03, 2012 last modified Apr 03, 2012 03:39 PM — filed under: , ,
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in recent articles in The News & Observer and the Scientific American blog.
Located in News / 2012 News
UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th
by maryruth.helms published Apr 09, 2012 last modified May 16, 2012 09:35 AM — filed under: , ,
UNC Cancer Care’s neuro-oncology program will recognize Ependymoma Awareness Day on April 19th, as part of the program’s overall efforts to increase public awareness of this rare tumor and the need for clinical studies to improve early diagnosis, standardize treatment and improve the health status of those living with this disease.
Located in News / 2012 News
Sharpless, Zanation honored as Health Care Heroes
by maryruth.helms published Mar 30, 2012 last modified Apr 10, 2012 01:17 PM — filed under: , ,
UNC Lineberger faculty members Ned Sharpless, MD, and Adam Zanation, MD, were honored for their achievements by Triangle Business Journal as 2012 Health Care Heroes.
Located in News / 2012 News
Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting
by maryruth.helms published Apr 10, 2012 last modified Apr 11, 2012 01:50 PM — filed under: , ,
Nancy DeMore, MD, and colleagues presented an abstract at the recent Society of Surgical Oncology 65th annual cancer symposium held in Orlando, Florida in March. Dr. DeMore is an associate professor of surgery and a member of UNC Lineberger.
Located in News / 2012 News
Gene switches do more than flip “on” or “off”
by maryruth.helms published Apr 11, 2012 last modified Nov 02, 2012 09:46 AM — filed under: ,
Chapel Hill - Anyone who’s tried a weekend home improvement project knows that to do a job right, you’ve got to have the right tools. For cells, these “tools” are proteins encoded by genes.
Located in News / 2012 News
Ten minutes could save your life: FREE Head & Neck Cancer Screenings
by maryruth.helms published Apr 12, 2012 — filed under: , ,
UNC Health Care will offer free screenings during Oral, Head and Neck Cancer Awareness Week, on Wednesday, April 25, from 1 - 4 p.m. in the Ear, Nose, & Throat Clinic on the ground floor of the N.C. Neurosciences Hospital.
Located in News / 2012 News
Kinase test may yield big gains for drug-resistant cancers
by maryruth.helms published Apr 12, 2012 last modified Apr 23, 2012 02:59 PM — filed under: ,
Chapel Hill, NC – In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases “en masse”, enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies.
Located in News / 2012 News